Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPremier Foods Regulatory News (PFD)

Share Price Information for Premier Foods (PFD)

Share Price is delayed by 15 minutes
Get Live Data
198.00    -2.40 (-1.20%)
Bid:
196.50
Ask:
196.80
Spread: 0.30 (0.153%)
Market Cap: £1.71b
PFD Live PriceLast checked at - London Stock Exchange

Intraday Premier Foods Share Chart

Directorate Change

14 Mar 2018 13:53

RNS Number : 7373H
Premier Foods plc
14 March 2018
 

 

 

Premier Foods plc ("Premier Foods" or the "Company")

14 March 2018

 

Board Retirement

 

Premier Foods announces that Tsunao Kijima, non-executive director, has advised the Company today that he intends to stand down as a director of Premier Foods on 23 March 2018, following his decision to retire from Nissin Foods Holdings Company Ltd ("Nissin"). Mr Kijima has served on the Board since July 2016 pursuant to the terms of the Relationship Agreement between the Company and Nissin.

 

Board Appointment

 

Following Mr Kijima's retirement, Shinji Honda will be appointed as a non-executive director and as Nissin's representative director pursuant to the Relationship Agreement, with effect from 23 March 2018.

 

Mr Honda is Chief Strategy Officer of Nissin, with responsibility for overseas operations, including Europe. Prior to joining Nissin in January 2018, Mr Honda spent his entire professional career at Takeda Pharmaceutical Company Limited ("Takeda"), a leading Japanese pharmaceutical company. He was named Member of the Board of Takeda in June 2013 and Corporate Strategy Officer in October 2014, having previously spent a significant amount of time overseeing Takeda's international operations where his responsibilities included President and CEO of Takeda North America.

 

Commenting on the changes Keith Hamill, Chairman of Premier Foods, said "I would like to take this opportunity to thank Mr Kijima for his significant contribution to both the Board and the partnership between Premier and Nissin, which has helped to ensure the successful launch of a number of exciting new products to market. We welcome Mr Honda to the Board and look forward to working with him in the future".

 

Mr Honda served as Member of the Board of Takeda Pharmaceutical Company Limited (listed on the first section of the Tokyo Stock Exchange) from June 2013 until June 2017. No further information is required to be disclosed pursuant to LR 9.6.13 R.

For further information please contact:

Andrew McDonald, General Counsel & Company Secretary +44 (0) 1727 815 850

Hannah Collyer, Corporate Affairs Director +44 (0) 1727 815 850

Richard Godden, Director of Investor Relations +44 (0) 1727 815 850

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAXZLFFVXFEBBF
Date   Source Headline
20th Mar 202012:03 pmRNSPrice Monitoring Extension
19th Mar 20202:00 pmRNSHolding(s) in Company
3rd Mar 20203:26 pmRNSHolding(s) in Company
2nd Mar 202011:55 amRNSTotal Voting Rights
28th Feb 202011:55 amRNSHolding(s) in Company
20th Feb 202012:49 pmRNSHolding(s) in Company
3rd Feb 20209:00 amRNSTotal Voting Rights
17th Jan 20207:00 amRNSQ3 Trading Update
2nd Jan 202011:30 amRNSTotal Voting Rights
17th Dec 20192:40 pmRNSDirector/PDMR Shareholding
10th Dec 201912:56 pmRNSHolding(s) in Company
10th Dec 20197:00 amRNSDirectorate Change
2nd Dec 20191:00 pmRNSTotal Voting Rights
22nd Nov 20191:00 pmRNSHolding(s) in Company
20th Nov 20193:06 pmRNSHolding(s) in Company
18th Nov 20197:00 amRNSAppointment of Joint Corporate Broker
12th Nov 20197:00 amRNSHalf-year Report
11th Nov 20191:19 pmRNSHolding(s) in Company
4th Nov 20192:14 pmRNSHolding(s) in Company
1st Nov 201912:17 pmRNSTotal Voting Rights
25th Oct 20199:00 amRNSApplication for Block Listing
14th Oct 20191:05 pmRNSApplication for Block Listing
14th Oct 20197:00 amRNSNotice of Results
1st Oct 201910:30 amRNSBlock listing Interim Review
1st Oct 201910:03 amRNSTotal Voting Rights
13th Sep 20194:01 pmRNSHolding(s) in Company
12th Sep 201912:00 pmRNSHolding(s) in Company
2nd Sep 201910:36 amRNSTotal Voting Rights
30th Aug 20197:00 amRNSDirectorate Change
6th Aug 201911:36 amRNSHolding(s) in Company
2nd Aug 201910:23 amRNSNotification in accordance with Listing Rule
1st Aug 201910:05 amRNSTotal Voting Rights and Capital
17th Jul 20192:19 pmRNSResult of AGM
17th Jul 20197:00 amRNSTrading Update
1st Jul 20193:12 pmRNSTotal Voting Rights
19th Jun 20194:00 pmRNSDirector/PDMR Shareholding
17th Jun 201911:56 amRNSAnnual Report and AGM Notice
12th Jun 20192:59 pmRNSDirector/PDMR Shareholding
7th Jun 20192:48 pmRNSDirector/PDMR Shareholding
3rd Jun 201911:54 amRNSTotal Voting Rights
30th May 20199:00 amRNSDirectorate Change
29th May 20191:09 pmRNSHolding(s) in Company
24th May 20192:58 pmRNSHolding(s) in Company
14th May 20197:00 amRNSPreliminary Results
1st May 201911:58 amRNSTotal Voting Rights
16th Apr 20199:00 amRNSNotification of Results
8th Apr 20192:08 pmRNSHolding(s) in Company
1st Apr 20191:20 pmRNSBlock listing Interim Review
1st Apr 20191:10 pmRNSTotal Voting Rights
29th Mar 20199:08 amRNSAppointment of Audit Committee Chairman

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.